NFE2L2 and hepatocellular carcinoma: To examine the relationship between the Nrf2 signaling pathway and sorafenib-resistance in HCC, Nrf2 expression was knocked down using a specific siRNA in sorafenib-resistant Huh7 cells, and a non-targeting siRNA was used as a control.